• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

Common test used on heart patients who need defibrillator implants unnecessary

, 26 August 2020/in E-News /by 3wmedia

New research from McMaster University suggests that a commonly performed test during certain types of heart surgery is not helpful and possibly harmful.
The testing procedure, known as defibrillator testing (DT), is commonly used on people who require implantable cardioverter-defibrillators (ICDs) to prevent sudden cardiac death. It involves putting the patient into cardiac arrest to determine if the defibrillator can first recognise, then successfully shock the patient back into a normal heart rhythm. It requires the use of general anaesthesia and is associated with uncommon but potentially life-threatening complications.
‘As with many things in medicine, technology evolves and our knowledge grows and we have presented good evidence that the DT, which has been in use for nearly 30 years, is no longer necessary,’ says lead author Jeff Healey, associate professor of medicine, in the Michael G. DeGroote School of Medicine at McMaster University.
‘Without the testing we can save a significant amount of time, money and more importantly, avoid potentially serious complications in patients who are receiving an ICD,’ he says.
Similar to a pacemaker, an ICD is a small battery-powered electrical impulse generator meant as a permanent safeguard against sudden arrhythmias. Each year, about 300,000 worldwide receive an ICD. Of these, approximately 70 per cent undergo the routine defibrillation testing that often leads to potential complications including possible harm from ICD shocks, says Healey.
‘Over the last 10 years, there has been an important shift in practice around the world towards ICD implantation without the test. However, until now, there has been no scientific evidence to support this change in practice. Our study now provides clear and robust evidence to guide practice.’
To test the procedure, Healey initiated a randomized trial, called the ‘Shockless IMPLant Evaluation (SIMPLE)’ study. It is the largest randomised clinical trial of ICD recipients to date, involving a cohort of 2,500 patients worldwide.
The trial compared standard DT in a patient to those who do not have the testing performed and revealed that those who received ICDs without DT did as well as those who underwent the standard testing. McMaster University

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:40:372020-08-26 14:40:42Common test used on heart patients who need defibrillator implants unnecessary

New interferon-free, all-oral 3D regimen achieves high SVR in chronic HCV genotype 1 patients

, 26 August 2020/in E-News /by 3wmedia

The new interferon-free, all-oral, three direct-acting-antiviral (3D) treatment regimen in development by AbbVie has achieved very high rates of virological response in patients chronically infected with hepatitis C virus (HCV) genotype 1 (GT1); according to the results of three studies presented at the International Liver CongressTM 2014.
The 3D regimen consists of the HCV NS3/4A protease inhibitor ABT-450 dosed with ritonavir, the NS5A inhibitor ABT-267, and the NS5B RNA polymerase inhibitor ABT-333.
‘Using this investigational 3D regimen, with or without ribavirin, these studies have demonstrated consistently high cure rates across a number of patient types, including the more difficult-to-treat subtype GT1a, and HCV patients with compensated cirrhosis,’ said EASL’s Scientific Committee Member Dr. Alessio Aghemo, Gastroenterology and Hepatology Unit, Ospedale Maggiore Policlinico, University of Milan. ‘The impressive SVR12 results seen are consistent with the results from AbbVie’s phase II studies,’ he added.
In the SAPPHIRE-I study, treatment na

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:40:372020-08-26 14:40:50New interferon-free, all-oral 3D regimen achieves high SVR in chronic HCV genotype 1 patients

Phantom limb pain relieved when amputated arm is put back to work

, 26 August 2020/in E-News /by 3wmedia

Max Ortiz Catalan has developed a new method for the treatment of phantom limb pain (PLP) after an amputation. The method is based on a unique combination of several technologies, and has been initially tested on a patient who has suffered from severe phantom limb pain for 48 years. A case study shows a drastic reduction of pain.
People who lose an arm or a leg often experience phantom sensations, as if the missing limb were still there. Seventy per cent of amputees experience pain in the amputated limb despite that it no longer exists. Phantom limb pain can be a serious chronic and deteriorating condition that reduces the quality of the person

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:40:372020-08-26 14:40:58Phantom limb pain relieved when amputated arm is put back to work

ZNA hospital group in Belgium extends Agfa HealthCare?s ICIS to integrate all medical images onto single cloud-based platform

, 26 August 2020/in E-News /by 3wmedia

The ZNA hospital network of Antwerp, Belgium, is extending its existing Agfa HealthCare ICIS imaging platform beyond radiology.. With the deployment, all other image-producing departments of the hospital group will be integrated, whether they produce DICOM or non-DICOM images. In addition, patient images from other facilities can be quickly and easily imported as well. The ICIS VIEW zero footprint image viewer will be implemented for internal and external image distribution, for all types of medical images.
With nine sites in the Antwerp area, ZNA is not only among Belgium

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:40:372020-08-26 14:40:44ZNA hospital group in Belgium extends Agfa HealthCare?s ICIS to integrate all medical images onto single cloud-based platform

UEA research shows gastric surgery halves risk of heart attack in obese people

, 26 August 2020/in E-News /by 3wmedia

Obese people who have stomach surgery to help them lose weight will halve their risk of heart attack according to new research from a team of doctors at the University of East Anglia, University of Manchester and University of Aberdeen.

The procedures, known as bariatric surgery, involve techniques such as gastric banding, which are available on the National Health Service (NHS), UK for selected patients.

New research published today in the International Journal of Cardiology reviewed data from 14 studies involving more than 29,000 patients who underwent bariatric surgery. It reveals that death rates were reduced by 40 per cent, and that heart attacks in particular were reduced by half

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:40:372020-08-26 14:40:52UEA research shows gastric surgery halves risk of heart attack in obese people

Acupuncture holds promise for treating inflammatory disease

, 26 August 2020/in E-News /by 3wmedia

When acupuncture first became popular in the Western Hemisphere it had its doubters. It still does. But over time, through detailed observation, scientists have produced real evidence that ancient Chinese practitioners of the medical arts were onto something.

Now new research documents a direct connection between the use of acupuncture and physical processes that could alleviate sepsis, a condition that often develops in hospital intensive care units, springs from infection and inflammation, and takes an estimated 250,000 lives in the United States every year.
‘Sepsis is the major cause of death in the hospital,’ says Luis Ulloa, an immunologist at Rutgers New Jersey Medical School who led the study. ‘But in many cases patients don

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:40:372020-08-26 14:41:01Acupuncture holds promise for treating inflammatory disease

?Map of pain? reveals how our ability to identify the source of pain varies across the body

, 26 August 2020/in E-News /by 3wmedia

‘Where does it hurt?’ is the first question asked to any person in pain.
A new UCL study defines for the first time how our ability to identify where it hurts, called ‘spatial acuity’, varies across the body, being most sensitive at the forehead and fingertips.

Using lasers to cause pain to 26 healthy volunteers without any touch, the researchers produced the first systematic map of how acuity for pain is distributed across the body.

With the exception of the hairless skin on the hands, spatial acuity improves towards the centre of the body whereas the acuity for touch is best at the extremities. This spatial pattern was highly consistent across all participants.

The experiment was also conducted on a rare patient lacking a sense of touch, but who normally feels pain. The results for this patient were consistent with those for healthy volunteers, proving that acuity for pain does not require a functioning sense of touch.

‘Acuity for touch has been known for more than a century, and tested daily in neurology to assess the state of sensory nerves on the body. It is striking that until now nobody had done the same for pain,’ says lead author Dr Flavia Mancini of the UCL Institute of Cognitive Neuroscience. ‘If you try to test pain with a physical object like a needle, you are also stimulating touch. This clouds the results, like taking an eye test wearing sunglasses. Using a specially-calibrated laser, we stimulate only the pain nerves in the upper layer of skin and not the deeper cells that sense touch.’

Volunteers were blindfolded and had specially-calibrated pairs of lasers targeted at various parts of their body. These lasers cause a brief sensation of pinprick pain. Sometimes only one laser would be activated, and sometimes both would be, unknown to participants. They were asked whether they felt one

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:40:372020-08-26 14:40:39?Map of pain? reveals how our ability to identify the source of pain varies across the body

Overnight home use of artificial pancreas ?feasible and beneficial?

, 26 August 2020/in E-News /by 3wmedia

The artificial pancreas promises to dramatically improve the quality of life for people with type 1 diabetes, which typically develops in childhood. All previous artificial pancreas trials, in hospitals and in home environments, have seen researchers strictly monitor patients. The latest trial, funded by JDRF, has shown for the first time that unsupervised use of the artificial pancreas overnight can be safe.

Type 1 diabetes is an autoimmune condition in which the pancreas is unable to produce insulin, a hormone which regulates blood glucose levels. High levels of glucose can seriously damage the body’s organs. People with type 1 diabetes currently rely on multiple insulin injections or pump infusions every day; a child diagnosed at the age of five faces up to 19,000 injections and 50,000 finger prick blood tests by the time they are 18.

Participants in the trial, all aged between 12 and 18, saw improved blood glucose control during the trial, experiencing fewer nights with hypoglycaemic episodes, generally known as

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:40:372020-08-26 14:40:47Overnight home use of artificial pancreas ?feasible and beneficial?

Halting immune response could save brain cells after stroke

, 26 August 2020/in E-News /by 3wmedia

A new study in animals shows that using a compound to block the body

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:40:372020-08-26 14:40:55Halting immune response could save brain cells after stroke

Obsessive-compulsive disorder questionnaire may give clues to other mental health problems

, 26 August 2020/in E-News /by 3wmedia

A shortened version of a questionnaire used by psychologists to assess risk factors for obsessive-compulsive disorder also may help determine the risk of depression and anxiety, according to a Baylor University study.

The revision may be a good fit for assessing the risk of mental health issues stemming from certain beliefs

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:40:372020-08-26 14:40:42Obsessive-compulsive disorder questionnaire may give clues to other mental health problems
Page 110 of 237«‹108109110111112›»

Latest issue of International Hospital

April 2024

5 November 2025

New NextBrain atlas enables unprecedented granularity in human brain imaging analysis

5 November 2025

ERIS project launches to standardise European simulation training

4 November 2025

Ageing populations are driving drug-resistant infection surge across Europe

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Tramstraat 15
5611CM Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription